Literature DB >> 2178807

Structure of alkaline phosphatases.

E E Kim1, H W Wyckoff.   

Abstract

The crystal structure of alkaline phosphatase (AP) from Escherichia coli, which is a prototype for mammalian APs, has been refined to a crystallographic R-factor of 0.184 at 2.0 A resolution. During the course of the refinement residues 380 to 410 were retraced and 190 to 200 were shifted by one residue, and substantial changes in the active site of the enzyme were made. Based on the refined structure and the sequences of mammalian enzymes (25-30% strict homology) we have modelled the core of the three dimensional structures of the mammalian alkaline phosphatases. Considerable circumstantial evidence suggests that this is valid despite the fact that the mammalian enzymes are larger, contain carbohydrate and are membrane associated through a phosphatidylinositol moiety. The active site of the molecule is highly conserved but specific changes in the secondary ligands to bound phosphate and the Mg metal are observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178807     DOI: 10.1016/0009-8981(90)90035-q

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  26 in total

1.  Time-resolved circularly polarized protein phosphorescence.

Authors:  J A Schauerte; D G Steel; A Gafni
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Artificial receptors for the recognition of phosphorylated molecules.

Authors:  Amanda E Hargrove; Sonia Nieto; Tianzhi Zhang; Jonathan L Sessler; Eric V Anslyn
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  One-step immunoassay for tetrabromobisphenol a using a camelid single domain antibody-alkaline phosphatase fusion protein.

Authors:  Jia Wang; Zuzana Majkova; Candace R S Bever; Jun Yang; Shirley J Gee; Ji Li; Ting Xu; Bruce D Hammock
Journal:  Anal Chem       Date:  2015-04-22       Impact factor: 6.986

Review 4.  Use of (113)Cd NMR to probe the native metal binding sites in metalloproteins: an overview.

Authors:  Ian M Armitage; Torbjörn Drakenberg; Brian Reilly
Journal:  Met Ions Life Sci       Date:  2013

5.  Solvent kinetic isotope effects of human placental alkaline phosphatase in reverse micelles.

Authors:  T M Huang; H C Hung; T C Chang; G G Chang
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

6.  Kinetics and crystal structure of a mutant Escherichia coli alkaline phosphatase (Asp-369-->Asn): a mechanism involving one zinc per active site.

Authors:  T T Tibbitts; X Xu; E R Kantrowitz
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

7.  Zinc status and vacuolar zinc transporters control alkaline phosphatase accumulation and activity in Saccharomyces cerevisiae.

Authors:  Wei Qiao; Charissa Ellis; Janet Steffen; Chang-Yi Wu; David J Eide
Journal:  Mol Microbiol       Date:  2009-03-03       Impact factor: 3.501

8.  Development of a one-step immunoassay for triazophos using camel single-domain antibody-alkaline phosphatase fusion protein.

Authors:  Kai Wang; Zhiping Liu; Guochun Ding; Ji Li; Natalia Vasylieva; Qing X Li; Dongyang Li; Shirley J Gee; Bruce D Hammock; Ting Xu
Journal:  Anal Bioanal Chem       Date:  2019-02-01       Impact factor: 4.142

9.  In vitro and in silico evaluation of the inhibitory effect of a curcumin-based oxovanadium (IV) complex on alkaline phosphatase activity and bacterial biofilm formation.

Authors:  G Katsipis; V Tsalouxidou; E Halevas; E Geromichalou; G Geromichalos; A A Pantazaki
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

10.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.